Titlesort descending Credit Start and expiration dates Member price Non-member price
Exploring the Risks of Social Media Use in Adolescents
1.0 NAPNAP Contact Hour, 0 Pharmacology Hour While technology has brought about advancements in every aspect of ordinary daily life, it has also created risks for the pediatric population not experienced in earlier generations. The use of social media has become common among all age groups, especially adolescents. This course will discuss the risks associated with social media use and the role of the NP in caring for children who participate on social media sites.
    • 1.00 Contact hours
05/09/2019 to 06/30/2021 $10.00 $10.00
Fever is Our Friend: How to Help Parents Not Fear Fever
1.0 NAPNAP Contact Hour, 0 Pharmacology Hour Fever is the most common chief complaint among children presenting to an emergency department. These visits are often fueled by the phenomenon known as fever phobia. Myths and misconceptions related to fever and its sequela often result in fever mistreatment and fever over treatment. This course will help novice though advanced providers strengthen their ability to confidently manage fever in children while providing sound anticipatory guidance to parents in an effort to allay their fears.
    • 1.00 Contact hours
04/24/2019 to 12/31/2021 $10.00 $20.00
Functional Gastrointestinal Disorder (FGID)
1.5 contact hour. Nearly every day in a primary care setting, providers will encounter a patient with a functional gastrointestinal disorder. This module contains three separate presentations by international experts on topics related to functional GI disorders. The first presentation addresses the art of delivering care to children with FGID’s. Together, a pediatric gastroenterologist and psychologist discuss the proper assessment and diagnostic criteria when FGID is suspected and the best way to discuss this diagnosis with the patient and family. The second module is a brief review of the benefits of hypnosis in pediatrics. Former APGNN President, Robin Shannon APRN, provides practical tips for utilization of hypnosis. In the last presentation of this module, Dr. Miranda van Tilburg, PhD explores the contribution of early adverse childhood experiences (ACE) to the development of pediatric FGID’s. Following review of this 90 minute module, the provider will gain deeper understanding of how to assess, diagnose, treat and discuss the diagnosis of FGID. They will also have an increased awareness to factors related to pediatric functional gastrointestinal disorders.
    • 1.50 Contact hours
10/10/2019 to 10/31/2021 $10.00 $20.00
Helping Breastfeeding Mothers Succeed
1.5 NAPNAP Contact Hour, 0 Pharmacology Hour This course will give APRNs the needed skills to assist the breastfeeding mother by applying evidence-based breastfeeding interventions. Identification of common breastfeeding barriers and management of basic lactation principles will be covered. This course is supported by the Breastfeeding Education Special Interest Group (BFE SIG)
    • 1.50 Contact hours
05/15/2019 to 12/31/2021 $15.00 $15.00
HPV Prevention: Nurses Get It Done!
The National HPV Vaccination Roundtable created the HPV Prevention: Nurses Get It Done! toolkit to help nurses at every practice level initiate and complete the HPV vaccination series.. Sponsored by the IMM SIG. At the core of the toolkit are 3 components that lead to vaccine completion: ⦁    Confidently recommend HPV vaccination ⦁    Compassionately respond to questions or concerns ⦁    Prepare your patient to receive the vaccine
    • 1.00 Contact hours
09/28/2020 to 09/30/2021 $10.00 $20.00
Human Trafficking: Raising Awareness to Identify Victims in the Clinical Setting

This course is not accredited by NAPNAP. This course is approved by Texas Health and Human Services to meet the requirements of H.B. 2059.

Providers must register for a free PedsCESM account, and be logged in to watch the webinar and receive the certificate.

This course was created in collaboration with Partners for Vulnerable Youth.

    • 0.00 Contact hours
10/06/2020 to 12/31/2021 $0.00 $0.00
Influenza Update! Advanced Practice Pearls on Treatment
What’s new in treating influenza? Dr. Charles Vega and Dr. Paul Auwaerter will discuss the latest evidence regarding the use of antiviral agents, reviewing their ability and efficacy to reduce influenza transmission. The use of these agents for patients with influenza who are at normal or high risk for complications will also be discussed.
    • 1.00 Contact hours
07/31/2020 to 07/30/2021 $0.00 $0.00
It Doesn't Have to Hurt: Innovative Pain Strategies for Pediatric Patients Undergoing Surgery
Pediatric patients with complex surgical problems are often a diagnostic dilemma. This presentation will cover strategies to manage pain in the pediatric post-operative patient. This will include assessment guidelines and pharmacologic and non-pharmacologic interventions. The presentation will conclude with specific case scenarios pertinent to common conditions in pediatric surgery.
    • 1.25 Contact hours
08/30/2020 to 08/31/2021 $6.00 $12.50
JPHC CE: Caring for the Digital Generation: Understanding Electronic Aggression
We live in a technology-saturated world, evidenced by widespread, global use of the Internet and other forms of technology. Technology offers nearly limitless connectivity, information-sharing, and communication. Unfortunately, with these opportunities come risks, especially for children, and pediatric healthcare providers have a responsibility to be aware and informed of these risks and how to respond. This article provides a breakdown of the broad phenomenon of electronic aggression and offers practice implications for healthcare providers. J PediatrHealth Care.(2020) Volume 35, Issue 1, p132−140
    • 1.00 Contact hours
12/17/2020 to 02/28/2022 $0.00 $10.00
JPHC CE: COVID-19: Impacts and Implications for Pediatric Practice
0.75 NAPNAP contact hour.Since the rapid emergence of the novel coronavirus in December of 2019 and subsequent development of a global pandemic, clinicians around the world have struggled to understand and respond effectively in health care systems already strained before this latest viral outbreak. Leaders are making policy decisions while balancing the slow and precise nature of science with the rapid need for lifesaving information.Pediatric nurse practitioners are ideally situated as a trusted source of health information for children. This continuing education article summarizes the latest evidence on the rapidly developing coronavirus pandemic. J Pediatr Health Care.(2020) 34, Issue 6, p619-629
    • 0.75 Contact hours
10/27/2020 to 12/31/2021 $0.00 $10.00
JPHC CE: JUULing Epidemic Among Youth: A Guide to Devices, Terminology, and Interventions
0.75 NAPNAP contact hour. In December 2018, the surgeon general warned of the e-cigarette epidemic among the youth of the United States (Office of the Surgeon General, 2018). As of December 3,2019, there have been 2,291 cases of hospitalization because of e-cigarette or vaping product use associated lung injury (EVALI) and 48 confirmed EVALI deaths reported to the Centers for Disease Control and Prevention. Over half of allreported EVALI cases have been of patients less than 24 years old, with 16% of those less than 18 years old (U.S. Department of Health and Human Services, Centers for Disease Control and Prevention, National Center for Disease Prevention and Health Promotion, 2019). July–August 2019 Volume 34, Issue 4, Pages 395–403.
    • 0.75 Contact hours
06/09/2020 to 08/31/2021 $0.00 $10.00
JPHC CE: Online Sexual Solicitation of Children and Adolescents
0.75 NAPNAP contact hours. The Internet is a relatively new and unregulated entity that can place children and adolescents at risk for a variety of negative and potentially dangerous exposures. One such risk is online sexual solicitations and interactions with older adolescents, peers, and adults. This continuing education article will explore online sexual solicitation of child and adolescents in terms of definition, epidemiology, predictors, consequences, and implications for practice. JPediatr Health Care. (2020) 34, Issue 6, p610−618
    • 0.75 Contact hours
10/28/2020 to 12/31/2021 $0.00 $10.00
JPHC CE: Oral b-Lactam Antibiotics for Pediatric Otitis Media, Rhinosinusitis, and Pneumonia
1.0 contact hour, 1.0 pharmacology. Acute otitis media, acute bacterial rhinosinusitis, and community- acquired pneumonia are major drivers of pediatric antibiotic consumption. With many available options and the added challenges of navigating antibiotic allergies and de-escalating from intravenous treatment for children requiring hospitalization, prescribing for these relatively simple infections can be a source of confusion and error. The purpose of this article is to evaluate the pharmacokinetic and pharmacodynamic properties of antibiotics commonly prescribed for these disease states, and to specifically compare anti-pneumococcal activity between oral beta-lactams. J Pediatr Health Care. (2019) V34, Issue 3 pgs. 291−300
    • 1.00 Contact hours
04/13/2020 to 06/30/2021 $0.00 $10.00
JPHC CE: Pediatric Psoriasis Comorbidities: Screening Recommendations for the Primary Care Provider
JPHC CE: 1.0 NAPNAP contact hour of which 0.25 contain pharmacology content. Psoriasis, which affects up to 2% of children may be associated with significant comorbidity, including obesity, diabetes, cardiovascular disease, depression, and reduced quality of life. Screening and decision-making require a multidisciplinary approach with the management of potential comorbidities championed by primary care providers and supported by respective specialists and subspecialists. Research into the comorbidities and systemic manifestations has generated significant data culminating in several proposals for a consensus guideline for both pediatric and nonpediatric populations. Our aim is to provide a summary targeted to the pediatric primary care provider from the best available evidence when caring for children with psoriasis. J Pediatr Health Care. (2021) 35, 337−350
    • 1.00 Contact hours
05/14/2021 to 06/30/2022 $0.00 $10.00
JPHC CE: Pharmacological Management of Spasticity in Children With Cerebral Palsy
1.5 NAPNAP contact hour of which contain 1.5 pharmacology content and 0.25 controlled substance. Cerebral palsy (CP), a nonprogressive disease of the central nervous system, is the most common motor disability in childhood. Patients with CP often have a multitude of associated comorbidities, including impact on muscle tone. There are four main types of CP, with spastic as the most commonly diagnosed. The American Academy of Neurology and Child Neurology Society released a practice parameter regarding the pharmacological management of CP-related spasticity in 2010. This continuing education review evaluates the available safety and efficacy evidence for oral and parenteral pharmacological agents used to reduce spasticity in children with CP and provides a reference for practitioners managing these patients. J Pediatr Health Care. (2020) 34, 409−509.
    • 1.50 Contact hours
07/31/2020 to 10/31/2021 $0.00 $10.00

Pages